Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Web-Based Training for Pain Management

9 november 2026 bijgewerkt door: Mujde CALIKUSU INCEKAR, Lokman Hekim University

Inadequate management of pain during vaccination may lead to negative vaccination experiences, needle fear, and future vaccine non-adherence in children. This study aims to develop a web-based pain management education program for nurses/midwives and parents to reduce vaccination-related pain in children and evaluate its effectiveness. The study will be conducted using a quasi-experimental pretest-posttest design with a non-randomized control group in two Family Health Centers. Pain will be assessed using the FLACC Pain Scale for children aged 0-3 years and the Wong-Baker FACES Pain Rating Scale for children aged 3 years and older. Pain management practices will be evaluated using an observation form. The information quality of the program will be assessed using DISCERN, and its usability will be evaluated using the System Usability Scale (SUS). Data will be analyzed using appropriate parametric and non-parametric tests. The intervention effect will be evaluated by examining the group-by-time interaction. Statistical significance will be set at p<0.05.

Studie Overzicht

Toestand

Werving

Conditie

Interventie / Behandeling

Studietype

Ingrijpend

Inschrijving (Geschat)

128

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

2 maanden tot 13 jaar (Kind)

Accepteert gezonde vrijwilligers

Ja

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

Nurses/Midwives:

  • Nurses or midwives who administer childhood vaccinations.
  • Nurses or midwives who voluntarily agree to participate in the study.

Parents:

  • Parents of children aged 2 months to 13 years.
  • Parents whose children are scheduled to receive routine vaccinations.
  • Parents who are able to read Turkish.

Exclusion Criteria:

Children:

  • Children with neurological disorders affecting pain perception.
  • Children who have received analgesic medications.
  • Children who are receiving antibiotic treatment.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Ondersteunende zorg
  • Toewijzing: Niet-gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Geen tussenkomst: Controlegroep
Experimenteel: Web Based Training Group

A web-based, evidence-based pain management education program will be provided separately to nurses/midwives and parents to reduce vaccination-related pain in children. The program includes educational modules consisting of text, visual materials, and videos. The content covers childhood pain, age-specific pain assessment, and evidence-based pharmacological and non-pharmacological pain management approaches. Nurses/midwives will complete approximately 90 minutes of education, while parents will complete approximately 40 minutes of education. Nurses/midwives will complete the program before the post-intervention observation period. Parents will receive the program link and will be asked to complete all modules before vaccination. Module completion will be monitored through the web-based platform.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Evidence-Based Pain Management Practices by Nurses/Midwives
Tijdsspanne: At baseline and during the post-intervention observation period, before, during, and immediately after vaccination.

Evidence-based pharmacological and non-pharmacological pain management practices performed by nurses/midwives before, during, and after childhood vaccination will be assessed using the Nurse/Midwife Observation Form. Each practice will be scored as performed (1) or not performed (0). Higher total scores indicate more frequent use of pain management practices.

At baseline and during the post-intervention observation period, before, during, and immediately after vaccination.
Evidence-Based Pain Management Practices by Parents
Tijdsspanne: At baseline and during the post-intervention observation period, before, during, and immediately after vaccination.

Evidence-based pharmacological and non-pharmacological pain management practices performed by parents before, during, and after childhood vaccination will be assessed using the Parent Observation Form. Each practice will be scored as performed (1) or not performed (0). Higher total scores indicate more frequent use of pain management practices.

At baseline and during the post-intervention observation period, before, during, and immediately after vaccination.
Vaccination-Related Pain Scores in Children Aged 0-Under 3 Years
Tijdsspanne: after vaccination implementation

Vaccination-related pain will be assessed using the FLACC (Face, Legs, Activity, Cry, Consolability) Pain Scale. Scores range from 0 to 10, with higher scores indicating greater pain intensity.

after vaccination implementation
Vaccination-Related Pain Scores in Children Aged 3 Years and Older
Tijdsspanne: after vaccination implementation

Vaccination-related pain will be assessed using the Wong-Baker FACES Pain Rating Scale. Scores range from 0 to 10, with higher scores indicating greater pain intensity.

after vaccination implementation

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Quality and Reliability of the Web-Based Pain Management Education Program
Tijdsspanne: After development of the web-based pain management education program and before its implementation

The quality and reliability of the web-based pain management education program will be evaluated by 5-7 academic experts using the DISCERN instrument. The instrument consists of 16 items and total scores range from 16 to 80. Higher scores indicate better information quality and reliability.

After development of the web-based pain management education program and before its implementation
Usability of the Web-Based Pain Management Education Program
Tijdsspanne: Immediately after completion of the web-based pain management education program

The usability of the web-based pain management education program will be evaluated using the 10-item System Usability Scale (SUS) by nurses/midwives and parents. Total scores range from 0 to 100, with higher scores indicating better usability. Scores of 65 or above will be considered acceptable usability.

Immediately after completion of the web-based pain management education program

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Sponsor

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

2 november 2026

Primaire voltooiing (Geschat)

30 september 2027

Studie voltooiing (Geschat)

30 september 2027

Studieregistratiedata

Eerst ingediend

4 november 2026

Eerst ingediend dat voldeed aan de QC-criteria

9 november 2026

Eerst geplaatst (Werkelijk)

16 november 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

16 november 2026

Laatste update ingediend die voldeed aan QC-criteria

9 november 2026

Laatst geverifieerd

1 november 2026

Meer informatie

Termen gerelateerd aan deze studie

Andere studie-ID-nummers

  • LHU-MCI-02

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .